130996-24-6(Dehydro Lacidipine) Product Description

Dehydro Lacidipine GR 510922qopenyl] GR 51092X (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-prphenyl]-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester Lacidipine BP Impurity B Lacidipine EP Impurity B diethyl 4-[2-[(E)-3-tert-butoxy-3-oxo-prop-1-enyl]phenyl]-2,6-dim ethyl-pyridine-3,5-dicarboxylate Imp. B (BP): Diethyl(E)-4-{2-[2-(tert-Butoxycarbonyl)vinyl]phenyl}-2,6-dimethylpyridine-3,5-dicarboxylate Lacidipine Impurity 2(Lacidipine BP Impurity B) Diethyl (E)-4-{2-[2-(tert-Butoxycar 3,5-Pyridinedicarboxylic acid, 4-[2-[(1E)-3-(1,1-dimethylethoxy)-3-oxo-1-propen-1-yl]phenyl]-2,6-dimethyl-, 3,5-diethyl ester 3,5-Pyridinedicarboxylicacid, 4-[2-[3-(1,1-dimethylethoxy)-3-oxo-1-propenyl]phenyl]-2,6-dimethyl-,diethyl ester, (E)- (9CI) Lacidipine EP Impurity B (Dehydro Lacidipine) GR 51092 (E)-Diethyl 4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethylpyridine-3,5-dicarboxylate (Lacidipine Impurity) Lacidipine Impurity B Lacidipine impurity II 130996-24-6 208538-73-9 Heterocyles Intermediates & Fine Chemicals Metabolites & Impurities Pharmaceuticals Heterocyles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals